title: Inhibition of cholesterol synthesis by cyclopropylamine derivatives of squalene in human hepatoblastoma cells in culture.
abstract: Two squalene derivatives, trisnorsqualene cyclopropylamine and trisnorsqualene N-methylcyclopropylamine, were synthesized and tested for inhibition of lanosterol and squalene epoxide formation from squalene in rat hepatic microsomes, and for the inhibition of cholesterol synthesis in human cultured hepatoblastoma (HepG2) cells. Trisnorsqualene cyclopropylamine inhibited [3H]-squalene conversion to [3H]squalene epoxide in microsomes (IC50 = 5.0 microM), indicating that this derivative inhibited squalene mono-oxygenase. Trisnorsqualene N-methylcyclopropylamine inhibited [3H]squalene conversion to [3H]lanosterol (IC50 = 12.0 microM) and caused [3H]-squalene epoxide to accumulate in microsomes, indicating that this derivative inhibited 2,3-oxidosqualene cyclase. Cholesterol biosynthesis from [14C]acetate in HepG2 cells was inhibited by both derivatives (IC50 = 1.0 microM for trisnorsqualene cyclopropylamine; IC50 = 0.5 microM for trisnorsqualene N-methylcyclopropylamine). Cells incubated with trisnorsqualene cyclopropylamine accumulated [14C]squalene, while cells incubated with trisnorsqualene N-methylcyclopropylamine accumulated [14C]squalene epoxide and [14C]squalene diepoxide. The concentration range of inhibitor which caused these intermediates to accumulate coincided with that which inhibited cholesterol synthesis. The results indicate that cyclopropylamine derivatives of squalene are effective inhibitors of cholesterol synthesis, and that substitutions at the nitrogen affect enzyme selectivity and thus the mechanism of action of the compounds.
authors.affiliation: Marion Merrell Dow Research Institute, Cincinnati, Ohio 45215.
authors.forename: W A
authors.initials: WA
authors.lastname: Van Sickle
authors.forename: M R
authors.initials: MR
authors.lastname: Angelastro
authors.forename: P
authors.initials: P
authors.lastname: Wilson
authors.forename: J R
authors.initials: JR
authors.lastname: Cooper
authors.forename: A
authors.initials: A
authors.lastname: Marquart
authors.forename: M A
authors.initials: MA
authors.lastname: Flanagan
mesh_terms: D000085:Acetates / Q000378:metabolism; D000818:Animals; D006528:Carcinoma, Hepatocellular; D002460:Cell Line; D002784:Cholesterol / Q000096:biosynthesis*; D006801:Humans; D007700:Kinetics; D008113:Liver Neoplasms; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology*; D010105:Oxygenases / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D013185:Squalene / Q000031:analogs & derivatives* / Q000378:metabolism* / Q000494:pharmacology; D050603:Squalene Monooxygenase
chemical_list: D000085:Acetates; C076515:trisnorsqualene cyclopropylamine; C076514:trisnorsqualene N-methylcyclopropylamine; D013185:Squalene; D002784:Cholesterol; D010105:Oxygenases; D050603:Squalene Monooxygenase